Tempus AI (NASDAQ:TEM) Given New $52.00 Price Target at Loop Capital

Tempus AI (NASDAQ:TEM) had its price objective decreased by Loop Capital from $57.00 to $52.00 in a research note released on Tuesday morning,Benzinga reports. Loop Capital currently has a buy rating on the stock.

A number of other equities research analysts have also weighed in on the company. Needham & Company LLC reiterated a “buy” rating and issued a $56.00 price objective on shares of Tempus AI in a research report on Tuesday. Piper Sandler reissued a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Wolfe Research started coverage on shares of Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price for the company. Bank of America boosted their price target on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Finally, Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and raised their price objective for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.36.

Tempus AI Stock Down 1.6 %

Tempus AI stock opened at $31.83 on Tuesday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI has a 1-year low of $22.89 and a 1-year high of $79.49. The firm has a 50-day moving average of $47.94 and a 200-day moving average of $47.28.

Insider Activity

In other Tempus AI news, EVP Andrew Polovin sold 51,504 shares of Tempus AI stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total value of $2,183,254.56. Following the completion of the transaction, the executive vice president now directly owns 246,085 shares of the company’s stock, valued at approximately $10,431,543.15. The trade was a 17.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the transaction, the insider now owns 16,164,449 shares in the company, valued at approximately $694,263,084.55. This represents a 2.39 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 865,041 shares of company stock worth $35,917,673.

Hedge Funds Weigh In On Tempus AI

Hedge funds have recently added to or reduced their stakes in the company. NEA Management Company LLC increased its holdings in shares of Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after purchasing an additional 813,169 shares in the last quarter. Novo Holdings A S bought a new stake in Tempus AI in the 2nd quarter worth about $142,605,000. ARK Investment Management LLC lifted its stake in Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after acquiring an additional 1,855,459 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its stake in Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock valued at $68,922,000 after acquiring an additional 1,145,698 shares during the period. Finally, Lingotto Investment Management LLP purchased a new stake in shares of Tempus AI during the 2nd quarter valued at about $32,685,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.